Pre-stabilisation announcement
Not for distribution, directly or indirectly, in or into the United States,
Canada, Japan or Australia or any jurisdiction in which such distribution would
be unlawful.
Sanitec Corporation
Stabilisation Notice
UBS Limited (contact: Gareth McCartney; telephone: 0044 20756 82227) hereby
gives notice that the Stabilisation Manager named below may stabilise the offer
of the following securities in accordance with Commission Regulation (EC) No.
2273/2003 implementing the Market Abuse Directive (2003/6) and MAR 2.3.5 (1) of
the Financial Conduct Authority Code of Market Conduct
The Securities:
Issuer:
Sanitec
Corporation
Offering securities:
Ordinary
Shares of €1
eachISIN:
FI4000072772
Offering description:
Initial
Public
Offering
Offering size:
52,173,914
shares
Offer
price:
SEK 61
Stabilisation:
Stabilisation Manager:
UBS Limited
Stabilisation period expected to start on:
9am CET 10
December 2013
Stabilisation period expected to end no later than:
Close of
business 8
January 2014
Maximum size of over-allotment facility:
7,826,086
million
shares
Conditions of use of over-allotment facility:
May be
exercised in
whole or in
part by the
Stabilisation
Manager, to
the extent
permitted by
applicable
law, at any
time during
the period
commencing
with
conditional
dealings and
ending 30
days
thereafter
Over-allotment Option:
Size:
Equivalent to
up to 15% of
the offering
Exercise period:
30 days from
the start of
conditional
dealings
(ending close
of business 8
January 2014)
Conditions of use of over-allotment option:
May be
exercised by
the
Stabilisation
Manager in
whole or in
part from
time to time
from 8am 10
December2013
to close of
business 8
January 2014
In connection with its Stabilisation activities Sofia IV S.à r.l. has granted
UBS Limited, on behalf of the Underwriters, an over-allotment option,
exercisable once for a period of 30 days after 10 December 2013 which, if
exercised will require Sofia IV S.à r.l. to sell up to 15 per cent. of the
aggregate number of Offering Shares available in the Offering (before any
exercise of the Over-allotment Option) at the Offer Price to cover short
positions arising from such over-allotments (if any) and/or sales of shares
effected by it during the Stabilisation period.
UBS Limited has agreed with Sanitec Corporation and Sofia IV S.à r.l.that any
over-allotment of the Offering Shares by it or any of its agents will be up to a
maximum of 15 per cent. of the total number of the Offering Shares (before any
exercise of the Over-allotment Option).
Number of Offering Shares: 52,173,914 million shares
Number of shares subject to the over-allotment option: 7,826,086 million shares
In connection with the offer of the above securities, the Stabilisation Manager
may over-allot the securities or effect transactions with a view to supporting
the market price of the securities at a level higher than that which might
otherwise prevail. However, there is no assurance that the Stabilisation Manager
will take any Stabilisation action and any Stabilisation action, if begun, may
be ended at any time.
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or dispose
of any securities of the Issuer in any jurisdiction.
The offer of the relevant securities when made are, with the exception of a
public offering in Sweden, only addressed to and directed at persons in member
states of the European Economic Area ("EEA") who are "qualified investors"
within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive
2003/71/EC and amendments thereto, including Directive 2010/73/EU to the extent
implemented in the relevant Member State of the EEA) and any implementing
measure in each relevant Member State of the EEA (the "Prospectus Directive")
("Qualified Investors").
In addition, if and to the extent that this announcement is communicated in, or
the offer of the securities to which it relates is made in, any EEA Member State
that has implemented Directive 2003/71/EC (together with any applicable
implementing measures in any Member State, the "Prospectus Directive") before
the publication of a prospectus in relation to the securities which has been
approved by the competent authority in that Member State in accordance with the
Prospectus Directive (or which has been approved by a competent authority in
another Member State and notified to the competent authority in that Member
State in accordance with the Prospectus Directive), this announcement and the
offer are only addressed to and directed at persons in that Member State who are
qualified investors within the meaning of the Prospectus Directive (or who are
other persons to whom the offer may lawfully be addressed) and must not be acted
on or relied on by other persons in that Member State.
The offer of the above securities and the distribution of this announcement and
other information in connection with the offer of the above securities in
certain jurisdictions may be restricted by law and persons into whose possession
any document or other information referred to herein comes should inform
themselves about and observe any such restriction. Any failure to comply with
these restrictions may constitute a violation of the securities laws of any such
jurisdiction.
This announcement is not an offer of securities for sale into the United States.
The securities have not been, and will not be, registered under the United
States Securities Act of 1933 and may not be offered or sold in the United
States absent registration or an exemption from registration. There will be no
public offer of securities in the United States.
Pre-stabilisation announcement
| Source: Sanitec